Abiopharma

Clinical trial NCT06638333 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-06-30 → 2025-12-26 3. primary completion date: 2025-06-30 → 2025-03-02 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04068155 updates: 1. completion date: 2025-01-01 → 2028-01-01 2. primary completion date: 2025-01-01 → 2027-01-01

Clinical trial NCT06949553 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2029-02-15 → 2025-08-28 3. primary completion date: 2028-05-15 → 2025-08-28 4. enrollment: 250 → 24 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04829383 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-10-01 → 2024-10-15 3. primary completion date: 2025-10-01 → 2024-06-19 4. enrollment: 50 → 6 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07492641: start date: 2026-05-20 → 2026-05-22.

Clinical trial NCT07559396 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-15 → 2026-05-29

Clinical trial NCT03485677 updates: 1. completion date: 2025-12-12 → 2025-12-26 2. primary completion date: 2025-12-12 → 2025-12-26

Clinical trial NCT06885177: primary completion date: 2026-05-01 → 2026-05-15.

Clinical trial NCT07504601: start date: 2026-06-18 → 2026-06-21.

Clinical trial NCT07553598: start date: 2026-05-01 → 2026-07-01.